Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006339:Heart Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000081:Acetamides; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D010647:Phenyl Ethers; D011412:Propanolamines